Russell Collighan

Title: Russell Collighan: Innovator in Polypeptide Research

Introduction

Russell Collighan is a notable inventor based in Birmingham, GB. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that have medical applications. His work focuses on modulating cell behavior, which has implications for various therapeutic areas.

Latest Patents

Collighan holds a patent for "Polypeptides and use thereof." This invention provides polypeptides capable of modulating tissue transglutaminase-induced cell behavior. The polypeptide comprises or consists of either (a) the amino acid sequence of a heparin-binding site of a tissue transglutaminase, or a functional fragment, variant, fusion, or derivative thereof. Alternatively, it may include (b) an antibody capable of binding to a heparin-binding site of a tissue transglutaminase, or an antigen-binding fragment or derivative thereof. The invention further outlines medical uses of these polypeptides and methods of treatment utilizing them.

Career Highlights

Russell Collighan is affiliated with Aston University, where he conducts his research and development work. His innovative approach to polypeptide research has positioned him as a key figure in his field. With a focus on practical applications, he aims to translate his findings into real-world medical solutions.

Collaborations

Collighan collaborates with esteemed colleagues such as Martin Griffin and Kamila Pytel. These partnerships enhance the research environment and foster innovation within the team.

Conclusion

Russell Collighan's contributions to polypeptide research exemplify the intersection of science and medicine. His patent and ongoing work at Aston University highlight his commitment to advancing therapeutic options through innovative research.